These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7669639)
21. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. Wilkinson JD; Williamson EM J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480 [TBL] [Abstract][Full Text] [Related]
22. Effect of ciclosporin A on epidermal keratinocytes in vitro: lack of a direct effect on calmodulin. Fairley JA; Fung PD; Ewing NM Skin Pharmacol; 1990; 3(3):149-56. PubMed ID: 2078349 [TBL] [Abstract][Full Text] [Related]
23. Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition. Müller K; Leukel P; Ziereis K; Gawlik I J Med Chem; 1994 May; 37(11):1660-9. PubMed ID: 8201600 [TBL] [Abstract][Full Text] [Related]
24. Changes of epidermal cell morphology and keratin expression induced by inhibitors of protein kinase C. Hegemann L; Wevers A; Bonnekoh B; Mahrle G J Dermatol Sci; 1992 Mar; 3(2):103-10. PubMed ID: 1376142 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin. Lee GL; Hait WN Life Sci; 1985 Jan; 36(4):347-54. PubMed ID: 2981390 [TBL] [Abstract][Full Text] [Related]
26. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. Gulino A; Barrera G; Vacca A; Farina A; Ferretti C; Screpanti I; Dianzani MU; Frati L Cancer Res; 1986 Dec; 46(12 Pt 1):6274-8. PubMed ID: 3022916 [TBL] [Abstract][Full Text] [Related]
27. Calcium/calmodulin regulation of the proliferation of human epidermal keratinocytes, dermal fibroblasts and mouse B16 melanoma cells in culture. Al-Ani AM; Messenger AG; Lawry J; Bleehen SS; MacNeil S Br J Dermatol; 1988 Sep; 119(3):295-306. PubMed ID: 2460125 [TBL] [Abstract][Full Text] [Related]
29. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors. Evans JF; Lévillé C; Mancini JA; Prasit P; Thérien M; Zamboni R; Gauthier JY; Fortin R; Charleson P; MacIntyre DE Mol Pharmacol; 1991 Jul; 40(1):22-7. PubMed ID: 1857337 [TBL] [Abstract][Full Text] [Related]
30. Effects of cyclosporin A and cilomilast on activated canine, murine and human keratinocytes. Bäumer W; Kietzmann M Vet Dermatol; 2007 Apr; 18(2):107-14. PubMed ID: 17355425 [TBL] [Abstract][Full Text] [Related]
31. MK 886, an antagonist of leukotriene generation, inhibits DNA synthesis in a subset of acute myeloid leukaemia cells. Khan MA; Hoffbrand AV; Mehta A; Wright F; Tahami F; Wickremasinghe RG Leuk Res; 1993 Sep; 17(9):759-62. PubMed ID: 8371575 [TBL] [Abstract][Full Text] [Related]
32. Growth inhibition of BALB/c mouse keratinocytes by TGF-beta 1 and CeReS-18 appears to act through distinct mechanisms. Betz NA; Fattaey HK; Johnson TC Exp Cell Res; 1996 Aug; 227(1):47-54. PubMed ID: 8806450 [TBL] [Abstract][Full Text] [Related]
34. The role of calmodulin in the regulation of osteoclastogenesis. Zhang L; Feng X; McDonald JM Endocrinology; 2003 Oct; 144(10):4536-43. PubMed ID: 12960067 [TBL] [Abstract][Full Text] [Related]
35. Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity. Müller K; Prinz H; Gawlik I; Ziereis K; Huang HS J Med Chem; 1997 Nov; 40(23):3773-80. PubMed ID: 9371243 [TBL] [Abstract][Full Text] [Related]
36. Keratinocyte growth inhibition by high-dose epidermal growth factor is mediated by transforming growth factor beta autoinduction: a negative feedback mechanism for keratinocyte growth. Yamasaki K; Toriu N; Hanakawa Y; Shirakata Y; Sayama K; Takayanagi A; Ohtsubo M; Gamou S; Shimizu N; Fujii M; Miyazono K; Hashimoto K J Invest Dermatol; 2003 Jun; 120(6):1030-7. PubMed ID: 12787131 [TBL] [Abstract][Full Text] [Related]
37. Biochemical activity, pharmacokinetics, and tolerability of MK-886, a leukotriene biosynthesis inhibitor, in humans. Depre M; Friedman B; Tanaka W; Van Hecken A; Buntinx A; DeSchepper PJ Clin Pharmacol Ther; 1993 May; 53(5):602-7. PubMed ID: 8387904 [TBL] [Abstract][Full Text] [Related]
38. A comparative study of the anti-proliferative effects of calmodulin antagonists in cultured cells--W7 derivatives of improved cytostatic potential. Barton CH; Blackburn GM; Rees R; Bleehen SS; Senior JH; Munro DS; MacNeil S Carcinogenesis; 1987 Jul; 8(7):919-23. PubMed ID: 3594725 [TBL] [Abstract][Full Text] [Related]
39. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo. Liu J; Qi S; Zhu H; Zhang J; Li Z; Wang T Chin Med J (Engl); 2002 May; 115(5):759-62. PubMed ID: 12133551 [TBL] [Abstract][Full Text] [Related]
40. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors. Lee E; Lindo T; Jackson N; Meng-Choong L; Reynolds P; Hill A; Haswell M; Jackson S; Kilfeather S Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]